Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
ArticlePubMedPMC 13
This delayed stomach emptying is part of how these medications reduce appetite and promote satiety
Gallbladder problems GLP-1 medications may increase the risk of gallstones and gallbladder inflammation, especially if you lose weight quickly
Cost-Effectiveness: Using single-use sterile water for a multi-day experiment would require discarding expensive peptides every single day
Increasing dietary intake of food rich in vitamin E and supplying vitamin E pill to the population may reduce the risk of nuclear cataract development (36), but most studies do not show results in agreement with this hypothesis, especially in studies regarding the role of vitamin E in cortical cataracts (37)